| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/02/1998 | CN1192139A Use of agonists or antagonists of P2 purinoceptors for the prevention of g lutamate-evoked cytotoxicity |
| 09/01/1998 | US5801228 Polymeric contrast agents for medical imaging |
| 09/01/1998 | US5801196 Methods of using emu oil and active fractions thereof as an insect repellent |
| 09/01/1998 | US5801174 Cerebrovascular disorders |
| 08/26/1998 | EP0859763A1 Dihydrophthalazine antagonists of excitatory amino acid receptors |
| 08/26/1998 | EP0859623A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 08/26/1998 | CN1191131A Herbal medicine for giving up drug |
| 08/19/1998 | EP0858807A2 Use of dopamine receptor antagonists in palliative tumor therapy |
| 08/13/1998 | WO1998034620A1 Methods for in vivo reduction of cyanide levels and compositions useful therefor |
| 08/13/1998 | CA2625727A1 Methods for the administration of amifostine |
| 08/12/1998 | CN1190098A Preparation, medicinal composition and application of grouped gensenoside |
| 08/12/1998 | CN1190003A Plumbism preventing detoxication mixture |
| 08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
| 08/11/1998 | US5792639 Paraoxonase polypeptides and use therefor |
| 08/04/1998 | US5789414 Protect dna from damage |
| 08/04/1998 | US5789406 Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them |
| 07/30/1998 | WO1998032863A2 Mammalian thioredoxin |
| 07/30/1998 | DE19718245C1 Synthetic tri:glyceride(s) useful as food additives |
| 07/30/1998 | CA2279241A1 Mammalian thioredoxin |
| 07/29/1998 | EP0855396A1 Thioctic acid metabolites and methods of use thereof |
| 07/29/1998 | CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis |
| 07/23/1998 | WO1998031795A2 Novel human metallothionein |
| 07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 07/23/1998 | CA2278596A1 Novel human metallothionein |
| 07/22/1998 | EP0853610A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 07/22/1998 | EP0725775B1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/22/1998 | CN1188412A Means for treating radiation injuries |
| 07/16/1998 | WO1998030220A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | CA2272941A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
| 07/09/1998 | WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/1998 | CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/08/1998 | EP0852232A1 Cyclic peptide compounds for pain treatment and their production process |
| 07/08/1998 | CN1187132A Processed ginseng having enhanced pharmacological effect |
| 07/07/1998 | US5776699 Method of identifying negative hormone and/or antagonist activities |
| 07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 06/23/1998 | US5770611 Indole derivatives as 5HT1 -like agonists |
| 06/18/1998 | WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
| 06/18/1998 | WO1998025626A1 Use of equilenin as an antioxidant |
| 06/18/1998 | WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 06/18/1998 | CA2272089A1 17.alpha.-dihydroequilenin for use as a medical antioxidant |
| 06/18/1998 | CA2272087A1 Use of equilenin as an antioxidant |
| 06/18/1998 | CA2272074A1 Use of 17.beta.-dihydroequilenin as an antioxidant |
| 06/16/1998 | US5766596 Aconite tuber-sulphur composite preparation and a process for the preparation thereof |
| 06/11/1998 | WO1998024770A1 New histidine derivatives, preparation process, and their use as free antiradical agents |
| 06/11/1998 | WO1998024434A1 Novel therapeutic application of a thienycyclohexylamine derivative |
| 06/10/1998 | EP0846265A1 Methods for g protein coupled receptor activity screening |
| 06/10/1998 | DE19650778A1 Dopamine receptor antagonists |
| 06/09/1998 | US5762936 Antioxidant derived from lentil and its preparation and uses |
| 06/09/1998 | CA2120133C Crystalline amifostine compositions and methods for the preparation and use of same |
| 06/03/1998 | EP0845539A1 Isolation and purification of tetrahydropyrimidine derivatives |
| 05/28/1998 | WO1998022109A1 Triaryl substituted imidazoles as glucagon antagonists |
| 05/28/1998 | CA2271893A1 Triaryl substituted imidazoles as glucagon antagonists |
| 05/27/1998 | EP0843726A1 Opioid antagonists and methods of their use |
| 05/27/1998 | EP0596032B1 Induction of cytotoxic t-lymphocyte responses |
| 05/26/1998 | US5756495 Nervous system disorders; alzheimer's disease |
| 05/20/1998 | EP0842192A2 Antimicrobial cationic peptides |
| 05/20/1998 | EP0842164A1 Cyclic amides and derivatives thereof |
| 05/20/1998 | EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis |
| 05/20/1998 | EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 05/14/1998 | WO1998019687A1 Natural teas for taking off the effects of drink and process for the production thereof |
| 05/13/1998 | EP0840770A1 Process for extraction of proanthocyanidins from botanical material |
| 05/12/1998 | US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
| 05/12/1998 | US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/06/1998 | EP0839534A1 Pharmacological association between n-acetylcystein and levulose for preventing cellular death and related diseases |
| 05/06/1998 | CN1181015A Reduction of infarct volume using citicoline |
| 05/05/1998 | US5746995 Diethylenetriaminepentaacetic acid |
| 04/30/1998 | WO1998017671A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/30/1998 | CA2268876A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/28/1998 | US5744483 Neuroprotective compounds |
| 04/22/1998 | EP0764027A4 Method for protection against genotoxic mutagenesis |
| 04/16/1998 | WO1998015521A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/16/1998 | CA2267129A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/15/1998 | EP0835251A1 Process for the production of lipoic acid |
| 04/15/1998 | EP0797442A4 Treatment of optic neuritis |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/09/1998 | WO1998014216A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | WO1998014182A1 Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 04/08/1998 | EP0833671A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 04/08/1998 | CN1178533A Process for isolating galanthamine |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/02/1998 | WO1998013055A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013036A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/01/1998 | EP0832654A2 Radiation-protecting agent |
| 04/01/1998 | EP0831930A1 Chelating polymers as contrast agents for medical imaging |
| 04/01/1998 | EP0831864A1 Processed ginseng having enhanced pharmacological effect |
| 04/01/1998 | EP0831849A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 04/01/1998 | EP0831841A1 Means for treating radiation injuries |
| 04/01/1998 | EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/18/1998 | EP0598753B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/12/1998 | WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 03/12/1998 | WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/12/1998 | WO1998009526A1 Antioxidant derived from lentil and its preparation and uses |
| 03/12/1998 | CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |